DLX2 antibody (Middle Region)
Quick Overview for DLX2 antibody (Middle Region) (ABIN452916)
Target
See all DLX2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- This antibody detects DLX2 at Center.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Purified through a protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human DLX2
-
-
-
-
Application Notes
-
Western blot: 1: 100 - 1: 500. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- DLX2 (Distal-Less Homeobox Protein 2 (DLX2))
-
Alternative Name
- DLX2
-
Background
- DLX2 is likely to play a regulatory role in the development of the ventral forebrain. It may play a role in craniofacial patterning and morphogenesis. Subcellular location: Nucleus (Potential).Synonyms: DLX-2, Homeobox protein DLX2
-
Molecular Weight
- 34243 Da
-
Gene ID
- 1746
-
NCBI Accession
- NP_004396
-
UniProt
- Q07687
Target
-